# Phio Pharmaceuticals Corp.: Form 8-K/A, filed Dec 6, 2019

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K/A
- Filed: 2019-12-06
- Accepted by EDGAR: Dec 6, 2019, 17:15 ET
- Period: 2019-11-12
- Accession: 0001683168-19-003908
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316819003908/phio_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316819003908/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316819003908/phio_8ka.htm

Filed Dec 6, 2019.
Source: SEC EDGAR, the filing index for accession 0001683168-19-003908. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
